NDC 0178-0894 Citranatal Dha

View Dosage, Usage, Ingredients, Routes, UNII

Product Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.
NDC Product Code:
0178-0894
Proprietary Name:
Citranatal Dha
Product Type: [3]
INACTIVATED PRODUCT and EXCLUDED the from NDC Directory
Labeler Code:
0178
Start Marketing Date: [9]
05-22-2014
Listing Expiration Date: [11]
12-31-2021
Exclude Flag: [12]
I
Code Navigator:

Product Characteristics

Color(s):
WHITE (C48325 - WHITE TO OFF WHITE)
BROWN (C48332 - CARAMEL)
Shape:
OVAL (C48345)
CAPSULE (C48336)
Size(s):
20 MM
23 MM
Imprint(s):
CN;1
Score:
1

Code Structure Chart

Product Details

What is NDC 0178-0894?

The NDC code 0178-0894 is assigned by the FDA to the product Citranatal Dha which is product labeled by Mission Pharmacal Company. The product's dosage form is . The product is distributed in a single package with assigned NDC code 0178-0894-30 30 blister pack in 1 carton / 1 kit in 1 blister pack. This page includes all the important details about this product, including active and inactive ingredients, pharmagologic classes, product uses and characteristics, UNII information and RxNorm crosswalk.

What are the uses for Citranatal Dha?

CitraNatal ® DHA is a multi-vitamin/mineral prescription drug indicated for use in improving the nutritional status of women prior to conception, throughout pregnancy, and in the postnatal period for both lactating and nonlactating mothers.

Which are Citranatal Dha UNII Codes?

The UNII codes for the active ingredients in this product are:

Which are Citranatal Dha Inactive Ingredients UNII Codes?

The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:

What is the NDC to RxNorm Crosswalk for Citranatal Dha?

RxNorm is a normalized naming system for generic and branded drugs that assigns unique concept identifier(s) known as RxCUIs to NDC products.The NDC to RxNorm Crosswalk for this produdct indicates multiple concept unique identifiers (RXCUIs) are associated with this product:
  • RxCUI: 1114508 - doconexent 250 MG / icosapent 0.625 MG Oral Capsule
  • RxCUI: 1114508 - docosahexaenoic acid 250 MG / eicosapentaenoic acid 0.625 MG Oral Capsule
  • RxCUI: 1114508 - DHA 250 MG / EPA 0.625 MG Oral Capsule

* Please review the disclaimer below.

Product Footnotes

[5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.

[9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.

[11] What is the Listing Expiration Date? - This is the date when the listing record will expire if not updated or certified by the product labeler.

[12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".